bioRxivImmunology
Pre-diabetes increases tuberculosis disease severity, while high body fat without impaired glucose tolerance is protective
R. Sinha, M. D. Ngo, S. Bartlett, H. Bielefeldt-Ohmann, S. Keshvari, S. Z. Hasnain, M. L. Donovan, J. C. Kling, A. Blumenthal, C. Chen, K. Short, K. Ronacher
Abstract
Type 2 diabetes (T2D) is a well-known risk factor for tuberculosis (TB), but little is known about pre-diabetes and the relative contribution of impaired glucose tolerance vs. obesity towards susceptibility to TB. Here, we developed a preclinical model of pre-diabetes and TB. Mice fed a high fat diet (HFD) for 12 weeks presented with impaired glucose tolerance and hyperinsulinemia compared to mice fed normal chow diet (NCD). Infection with M. tuberculosis (Mtb) H37Rv after the onset of dysglycemia was associated with significantly increased lung pathology, lower concentrations of TNF-a, IFN-g, IFN-{beta} and IL-10 and a trend towards higher bacterial burden at 3 weeks post infection. To determine whether the increased susceptibility of pre-diabetic mice to TB is reversible and is associated with dysglycemia or increased body fat mass, we performed a diet reversal experiment. Pre-diabetic mice were fed a NCD for 10 additional weeks (HFD/NCD) at which point glucose tolerance was restored, but body fat mass remained higher compared to control mice that consumed NCD throughout the entire experiment (NCD/NCD). Upon Mtb infection HFD/NCD mice had significantly lower bacterial burden compared to NCD/NCD mice and this was accompanied by restored IFN-{gamma} responses. Our findings demonstrate that pre-diabetes increases susceptibility to TB, but a high body mass index without dysglycemia is protective. This murine model offers the opportunity to further study the underlying immunological, metabolic and endocrine mechanisms of this association.
- organism: mouse
- assay: proteomics
- assay: metabolomics
- research focus: host-pathogen & immune response
- research focus: metabolism & bioenergetics
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Chronic hyperglycemia drives alterations in macrophage effector function in pulmonary tuberculosis
S. Panda, D. M. Seelan, … A. Singh·bioRxiv·Jan 18, 2022
- The PPE2 protein of Mycobacterium tuberculosis is responsible for the development of hyperglycemia and insulin resistance during tuberculosis
Manoj Kumar Bisht, Vandana Maurya, … Sangita Mukhopadhyay·bioRxiv·Aug 13, 2025
- Disparate effects of metformin on Mycobacterium tuberculosis infection in diabetic and non-diabetic mice
H. Sathkumara, K. Hansen, … A. Kupz·Antimicrobial Agents and ChemotherapyPeer-reviewed·Dec 16, 2020
- Dysglycemia is associated with Mycobacterium tuberculosis lineages in tuberculosis patients of North Lima - Peru.
Kattya Lopez, María B. Arriaga, … Roger I. Calderon·PLoS ONEPeer-reviewed·Jan 28, 2021
- A blunted GPR183/oxysterol axis during dysglycemia results in delayed recruitment of macrophages to the lung during M. tuberculosis infection
M. D. Ngo, S. Bartlett, … K. Ronacher·bioRxiv·Jan 5, 2022
- Diabetes mellitus and tuberculosis comorbidity induce unique microbial gut dysbiosis and associated metabolome.
Suchitra Jena, Nikhil Bhalla, … Ranjan Kumar Nanda·bioRxiv·Mar 9, 2025